As cited by the research report titled ‘Intracardiac Echocardiography (ICE) and Intravascular Ultrasound (IVUS) Market Size By Application (Electrophysiology Procedures, Left Atrial Appendage Closure, Septal Defects), By End-use (Hospitals, Catheterization Laboratories), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with MarketStudyReport, global intracardiac echocardiography (ICE) and intravascular ultrasound (IVUS) market is estimated to expand significantly over 2021-2027.
 

Rising demand for medical imaging technologies coupled with increasing prevalence of chronic diseases are majorly driving global intracardiac echocardiography and intravascular ultrasound market growth. In addition, technological advancements and subsequent introduction of innovative devices are positively swaying the industry dynamics.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4202303/
 

For the record, intracardiac echocardiography (ICE) is an imaging technique that offers high-resolution and real-time visualization of cardiac structures, allowing continuous monitoring of catheter inside the heart, as well as enabling for early detection of any procedural complications like thrombus formation or pericardial effusion.
 

On the basis of applications, global intracardiac echocardiography and intravascular ultrasound industry is segmented into left atrial appendage closure, electrophysiology procedures, septal defects and others.
 

Among these, the others application segment is estimated to expand at a strong CAGR through the projected timeline owing to increasing demand for advanced imaging modalities in minimally invasive surgeries, including transcatheter valve replacement. Moreover, rising product adoption to lower procedural complications with superior visualization of complex peripheral and coronary structures is propelling the segmental growth over the estimated timeline.
 

Considering end user range, the marketplace is categorized into hospitals, catheterization laboratories, and others. Among these, the others segment accounted for around USD 95 million in 2020, and is likely to expand at a significant rate over 2021-2027, on account of rapid expansion of specialty facilities that provide diagnosis and treatment for many complex structural diseases.
 

On the geographical front, Middle East & Africa is likely to expand at a 3.9% CAGR and garner notable returns over the estimated timeline, primarily driven by rising frequency of diseases along with growing demand for advanced diagnostic imaging products. In addition, increasing focus on expanding the healthcare infrastructure is poised to create lucrative prospects for the regional market development as well.
 

Leading players profiled in the worldwide intracardiac echocardiography (ICE) and intravascular ultrasound (IVUS) industry are Koninklijke Philips N.V., Siemens Healthcare GmbH, Conavi Medical Inc., Nipro Corporation (Infraredx Inc.), Johnson & Johnson (Biosense Webster Inc.), Boston Scientific Corporation, and Abbott Laboratories.